Sickle cell disease in Ontario, Canada: an epidemiologic profile based on health administrative data.

CMAJ open Pub Date : 2023-07-01 DOI:10.9778/cmajo.20220145
Jacob Pendergrast, Lanre Tunji Ajayi, Eliane Kim, Michael A Campitelli, Erin Graves
{"title":"Sickle cell disease in Ontario, Canada: an epidemiologic profile based on health administrative data.","authors":"Jacob Pendergrast,&nbsp;Lanre Tunji Ajayi,&nbsp;Eliane Kim,&nbsp;Michael A Campitelli,&nbsp;Erin Graves","doi":"10.9778/cmajo.20220145","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The number of patients with sickle cell disease in Ontario, Canada, is unknown. In the absence of a formal registry, we performed a study to determine an approximate census via analysis of health administrative databases.</p><p><strong>Methods: </strong>We identified Ontario patients with a diagnosis of sickle cell disease through queries of the Discharge Abstract Database, National Ambulatory Care Reporting System and Newborn Screening Ontario database. The period of inquiry was Apr. 1, 2007, through Mar. 31, 2017. We identified repeat interactions by the same patient by cross-referencing provincial health insurance plan numbers.</p><p><strong>Results: </strong>We documented health care system interactions for 3418 unique patients (1912 [55.9%] female, median age at the time of identification 24 yr). Over the 10-year study period, patients visited the emergency department a median of 2 (interquartile range [IQR] 1-7) times and an average of 6.69 (standard deviation [SD] 26.71) times, and were admitted to hospital a median of 1 (IQR 1-5) time and an average of 4.38 (SD 8.53) times for treatment related to sickle cell disease. A total of 229 patients (6.7%) died during the study period, with an average age at death of 55 years. Even without accounting for the effects of immigration, the rate of natural increase slowed slightly over the study period owing to a decrease in the annual number of affected births.</p><p><strong>Interpretation: </strong>The estimated prevalence of patients with sickle cell disease in Ontario in 2007/08-2016/17 was 1 in 4200, and affected patients' need for hospital-based care was substantial, although highly variable. Similar queries of health administrative databases may be feasible in other Canadian provinces.</p>","PeriodicalId":10432,"journal":{"name":"CMAJ open","volume":"11 4","pages":"E725-E733"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0d/2b/cmajo.20220145.PMC10435244.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CMAJ open","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.9778/cmajo.20220145","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The number of patients with sickle cell disease in Ontario, Canada, is unknown. In the absence of a formal registry, we performed a study to determine an approximate census via analysis of health administrative databases.

Methods: We identified Ontario patients with a diagnosis of sickle cell disease through queries of the Discharge Abstract Database, National Ambulatory Care Reporting System and Newborn Screening Ontario database. The period of inquiry was Apr. 1, 2007, through Mar. 31, 2017. We identified repeat interactions by the same patient by cross-referencing provincial health insurance plan numbers.

Results: We documented health care system interactions for 3418 unique patients (1912 [55.9%] female, median age at the time of identification 24 yr). Over the 10-year study period, patients visited the emergency department a median of 2 (interquartile range [IQR] 1-7) times and an average of 6.69 (standard deviation [SD] 26.71) times, and were admitted to hospital a median of 1 (IQR 1-5) time and an average of 4.38 (SD 8.53) times for treatment related to sickle cell disease. A total of 229 patients (6.7%) died during the study period, with an average age at death of 55 years. Even without accounting for the effects of immigration, the rate of natural increase slowed slightly over the study period owing to a decrease in the annual number of affected births.

Interpretation: The estimated prevalence of patients with sickle cell disease in Ontario in 2007/08-2016/17 was 1 in 4200, and affected patients' need for hospital-based care was substantial, although highly variable. Similar queries of health administrative databases may be feasible in other Canadian provinces.

Abstract Image

Abstract Image

Abstract Image

加拿大安大略省镰状细胞病:基于卫生行政数据的流行病学概况
背景:在加拿大安大略省,镰状细胞病患者的数量是未知的。在没有正式登记的情况下,我们进行了一项研究,通过分析卫生行政数据库来确定近似的人口普查。方法:我们通过查询出院摘要数据库、全国门诊报告系统和新生儿筛查安大略省数据库,确定安大略省诊断为镰状细胞病的患者。调查期间为2007年4月1日至2017年3月31日。我们通过交叉参考省健康保险计划号码确定了同一患者的重复互动。结果:我们记录了3418例独特患者的医疗保健系统相互作用(1912例[55.9%]女性,确诊时中位年龄24岁)。在10年的研究期间,患者就诊急诊科的中位数为2次(四分位间距[IQR] 1-7),平均为6.69次(标准差[SD] 26.71),因镰状细胞病相关治疗住院的中位数为1次(IQR 1-5),平均为4.38次(SD 8.53)。研究期间共有229例(6.7%)患者死亡,平均死亡年龄为55岁。即使不考虑移民的影响,在研究期间,由于每年受影响的出生人数减少,自然增长率也略有放缓。解释:2007/08-2016/17年安大略省镰状细胞病患者的估计患病率为1 / 4200,受影响患者对医院护理的需求很大,尽管差异很大。在加拿大其他省份,对卫生行政数据库的类似查询可能也是可行的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信